Bankruptcy Judge Approves Purdue Pharma’s $7 Million Executive Bonus Plan

Bankruptcy Judge Approves Purdue Pharma’s $7 Million Executive Bonus Plan
A pharmacist holds a bottle of OxyContin made by Purdue Pharma, at a pharmacy in Provo, Utah, on May 9, 2019. George Frey/Reuters
Reuters
Updated:

A bankruptcy judge on Monday approved up to $7.1 million in bonuses for five executives of Purdue Pharma, the bankrupt maker of OxyContin, at a hearing at which he faced blunt criticism for his handling of the case from a woman whose son died of an opioid overdose.

Bankruptcy Judge Robert Drain in White Plains, New York, signed off on the executive incentive plan at the conclusion of the virtual hearing.